Patents/Assignees

ADVAGENE BIOPHARMA CO., Ltd.

2 patents in portfolio

US12589149utility2026
Method of Modulating Mucosal Immunogenicity
0 cites
US11986520utility2024
Method for the Prophylaxis or Treatment of Coronavirus Infection Using an Immunomodulator and Vaccine Compositions Comprising the Same
0 cites